{
  "meta": {
    "title": "9_Dementia",
    "url": "https://brainandscalpel.vercel.app/9-dementia-c283a255.html",
    "scrapedAt": "2025-11-30T12:35:35.739Z"
  },
  "questions": [
    {
      "text": "Which of the following features differentiate delirium from dementia in Alzheimer's disease?",
      "choices": [
        {
          "id": 1,
          "text": "Acuity of onset and agitation"
        },
        {
          "id": 2,
          "text": "Acuity of onset and loss of consciousness"
        },
        {
          "id": 3,
          "text": "Visual hallucinations and impaired memory"
        },
        {
          "id": 4,
          "text": "Agitation and irritation"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Delirium</strong> is characterized by <strong>acute onset</strong> of symptoms&nbsp;and is often accompanied by diminished or&nbsp;<strong>loss&nbsp;of consciousness and cognition. </strong>This feature is useful to clinically differentiate between delirium and dementia.&nbsp;</p>\n<p>Dementia&nbsp;is a group of diseases marked by chronic,&nbsp;progressive cognitive impairment&nbsp;with&nbsp;clear consciousness.&nbsp;</p><hr><h3>Related Pearl: Delirium vs Dementia</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Features</strong></p>\n</td>\n<td>\n<p><span><strong>Delirium</strong></span></p>\n</td>\n<td>\n<p><span><strong>Dementia</strong></span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Presentation</strong></td>\n<td>\n<p><span>Hallmark is impaired consciousness</span></p>\n</td>\n<td>\n<p><span>Loss of memory and intellectual abilities</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong><span>Commonly seen in&nbsp;</span></strong></p>\n</td>\n<td>\n<p><span>Children and elderly&nbsp;</span></p>\n</td>\n<td>\n<p><span>Elderly&nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Associated physical findings</strong></span></p>\n</td>\n<td>\n<ul>\n<li><span>Acute medical illness&nbsp;</span></li>\n<li><span>Autonomic dysfunction</span></li>\n<li><span>Abnormal EEG&nbsp;</span></li>\n<li><span>Carphologia or&nbsp;floccillation&nbsp;(picking movements at cover-sheets and clothes)&nbsp;</span></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><span>No medical illness</span></li>\n<li><span>Little autonomic dysfunction</span></li>\n<li><span>Normal EEG&nbsp;</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Psychological findings</strong></span></p>\n</td>\n<td>\n<ul>\n<li><span>Impaired consciousness</span></li>\n<li><span>Illusion, delusion&nbsp;</span></li>\n<li><span>Sundowning (symptoms much worse at night)&nbsp;</span></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><span>Normal consciousness</span></li>\n<li><span>Depressed mood&nbsp;</span></li>\n<li><span>Personality changes in early stages in Pick&rsquo;s disease&nbsp;<br /></span></li>\n<li><span>Sundowning (symptoms much worse at night)&nbsp;</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Course</strong></span></p>\n</td>\n<td>\n<ul>\n<li><span>Develops quickly</span></li>\n<li><span>Fluctuating course with lucid intervals (waxing and waning)&nbsp;</span></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><span>Insidious-onset</span></li>\n<li><span>Progressive downhill course</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p><span><strong>Etiology</strong></span></p>\n</td>\n<td>\n<ul>\n<li><span>CNS disease (E.g: Huntington or Parkinson disease)</span></li>\n<li><span>CNS trauma</span></li>\n<li><span>CNS infection (E.g: Meningitis)</span></li>\n<li><span>Systemic disease (E.g., hepatic, cardiovascular)</span></li>\n<li><span>Substance abuse/withdrawal</span></li>\n<li><span>HIV infection</span></li>\n<li><span>Prescription drug overdose (E.g: atropine)&nbsp;</span></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><span>Alzheimer's disease</span></li>\n<li><span>Vascular disease (15-30% of all dementias)</span></li>\n<li><span>CNS disease (E.g., Huntingtons or Parkinsons disease)</span></li>\n<li><span>CNS infection (HIV, Prion diseases)</span></li>\n<li><span>Lewy body dementia</span></li>\n<li><span>Pick's disease (Frontotemporal dementia)&nbsp;</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p><span><strong>Treatment:</strong></span></p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p><span>Treat the underlying medical cause</span></p>\n</td>\n<td>\n<p><span>Acetylcholinesterase inhibitors&nbsp;(donepezil, rivastigmine) and&nbsp;</span><span>NMDA antagonist (memantine)</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6709",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is a type of cortical dementia?",
      "choices": [
        {
          "id": 1,
          "text": "Parkinson's disease"
        },
        {
          "id": 2,
          "text": "Huntington’s disease"
        },
        {
          "id": 3,
          "text": "Alzheimer’s disease"
        },
        {
          "id": 4,
          "text": "Wilson's disease"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Alzheimer's disease</strong> is an example of cortical dementia.</p>\n<p><strong>Dementia</strong> is defined as a disease process marked by progressive cognitive impairment in clear consciousness. Depending on the site of the cerebral lesions, the dementias are classified as <strong>cortical</strong> or <strong>subcortical.</strong></p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Cortical dementia</strong> <strong>&nbsp;</strong></td>\n<td><strong>Subcortical dementia</strong>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Site of lesion </strong> <strong>&nbsp;</strong></td>\n<td>Cortex</td>\n<td>Thalamus, basal ganglia, cerebellum, brain stem</td>\n</tr>\n<tr>\n<td><strong>Higher cortical symptoms</strong></td>\n<td>\n<p>Aphasia</p>\n<p>Apraxia</p>\n<p>Agnosia</p>\n<p>Prosopagnosia</p>\n<p>Acalculia</p>\n</td>\n<td>No</td>\n</tr>\n<tr>\n<td><strong>Motor symptoms</strong></td>\n<td>No</td>\n<td>\n<p>Dysarthria</p>\n<p>Tremors</p>\n<p>Ataxia</p>\n<p>Rigidity</p>\n</td>\n</tr>\n<tr>\n<td><strong>Memory</strong></td>\n<td>Recall and recognition are impaired</td>\n<td>Recall is impaired</td>\n</tr>\n<tr>\n<td><strong>Examples</strong></td>\n<td>\n<ul>\n<li>Alzheimer's disease</li>\n<li>Frontotemporal dementia</li>\n<li>Creutzfeldt Jakob disease</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Parkinson's disease</li>\n<li>Progressive supranuclear palsy</li>\n<li>Huntington's disease</li>\n<li>Wilson's disease</li>\n<li>Idiopathic basal ganglia calcification&nbsp;</li>\n<li>Normal-pressure hydrocephalus</li>\n<li>Vascular dementia</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0310",
      "difficulty": "easy"
    },
    {
      "text": "If identified and intervened early, rapid clinical improvement can be expected in a patient with which of the following causes of dementia ?",
      "choices": [
        {
          "id": 1,
          "text": "Vascular dementia"
        },
        {
          "id": 2,
          "text": "Creutzfeldt-Jakob disease"
        },
        {
          "id": 3,
          "text": "Normal pressure hydrocephalus"
        },
        {
          "id": 4,
          "text": "Huntington’s disease"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>If diagnosed and intervened early,&nbsp;clinical improvement can be expected with&nbsp;<strong>normal pressure hydrocephalus</strong>&nbsp;(NPH), as it is a <strong>reversible</strong> cause of dementia.</p>\n<p>Normal pressure hydrocephalus can present with the following triad (<strong>Adam&rsquo;s</strong>&nbsp;triad&nbsp;or <strong>Hakim's</strong>&nbsp;triad), remembered as:</p>\n<ol>\n<li>Urinary incontinence (wet)</li>\n<li>Dementia (wacky)</li>\n<li>Gait disturbance (wobbly) &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</li>\n</ol>\n<p>Causes of dementia:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Reversible</strong></td>\n<td><strong>Irreversible</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Intracranial tumors</li>\n<li>Subdural hematoma</li>\n<li>Hypothyroidism</li>\n<li>Autoimmune encephalopathy</li>\n<li>Vitamin B12 deficiency</li>\n<li>Meningitis&nbsp;</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Alzheimer's disease</li>\n<li>Huntington's disease</li>\n<li>Lewy body disease</li>\n<li>Vascular dementia</li>\n<li>Creutzfeld-Jacob disease</li>\n<li>Pick's disease</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Differential diagnosis of dementia</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Condition</strong></span></td>\n<td><span><strong>Features</strong></span></td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Alzheimer&rsquo;s disease</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Insidious onset</span></li>\n<li><strong><span>Short-term memory loss</span></strong></li>\n<li><span>Language deficits and spatial disorientation</span></li>\n<li><span>Later, personality changes</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Vascular Dementia</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Stepwise decline</span></li>\n<li><strong><span>Early executive dysfunction</span></strong></li>\n<li><span>Cerebral infarction &amp;/or deep white matter changes on neuroimaging</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Frontotemporal dementia</strong></span></div>\n<div><span><strong>(Pick&rsquo;s disease)</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Early <strong>personality changes</strong></span></li>\n<li><span>Apathy, disinhibition &amp; compulsive behaviors</span></li>\n<li><span>Frontotemporal atrophy on neuroimaging</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Dementia with Lewy bodies</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span><strong>Visual Hallucination</strong></span></li>\n<li><span>Spontaneous parkinsonism</span></li>\n<li><span>Fluctuating cognition</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Normal-pressure hydrocephalus</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Gait abnormalities&nbsp;</span></li>\n<li><span>Urinary Incontinence</span></li>\n<li><span>Dementia</span></li>\n<li><strong><span>Dilated ventricles on neuroimaging</span></strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Creutzfeldt-Jakob disease</strong></span></div>\n<div><span><strong>(Prion disease)</strong></span></div>\n</td>\n<td>\n<ul>\n<li><strong><span>Behavioral changes</span></strong></li>\n<li><span>Rapidly progressive</span></li>\n<li><span>Myoclonus and/or seizures</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0305",
      "difficulty": "medium"
    },
    {
      "text": "In a patient being evaluated for cognitive and memory deficits, which of the following clinical features would favor a diagnosis of subcortical dementia?",
      "choices": [
        {
          "id": 1,
          "text": "Dystonia"
        },
        {
          "id": 2,
          "text": "Aphasia"
        },
        {
          "id": 3,
          "text": "Prosopagnosia"
        },
        {
          "id": 4,
          "text": "Apraxia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Dystonia</strong> is a feature of subcortical dementia.</p>\n<p><strong>Extrapyramidal symptoms</strong> along with memory deficits are typical of subcortical dementia.</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Cortical dementia</strong> <strong>&nbsp;</strong></td>\n<td><strong>Subcortical dementia</strong>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Site of lesion </strong><strong>&nbsp;</strong></td>\n<td>Cortex</td>\n<td>Thalamus, basal ganglia, cerebellum, brain stem</td>\n</tr>\n<tr>\n<td><strong>Higher cortical symptoms</strong></td>\n<td>\n<p>Aphasia</p>\n<p>Apraxia</p>\n<p>Agnosia</p>\n<p>Prosopagnosia</p>\n<p>Acalculia</p>\n</td>\n<td>No</td>\n</tr>\n<tr>\n<td><strong>Motor symptoms</strong></td>\n<td>No</td>\n<td>\n<p>Dysarthria</p>\n<p>Tremors</p>\n<p>Ataxia</p>\n<p>Rigidity</p>\n</td>\n</tr>\n<tr>\n<td><strong>Memory</strong></td>\n<td>Recall and recognition are impaired</td>\n<td>Recall is impaired</td>\n</tr>\n<tr>\n<td><strong>Examples</strong></td>\n<td>\n<ul>\n<li>Alzheimer's disease</li>\n<li>Frontotemporal dementia</li>\n<li>Creutzfeldt Jakob disease</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Parkinson's disease</li>\n<li>Progressive supranuclear palsy</li>\n<li>Huntington's disease</li>\n<li>Wilson's disease</li>\n<li>Idiopathic basal ganglia calcification&nbsp;</li>\n<li>Normal-pressure hydrocephalus</li>\n<li>Vascular dementia</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0307",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a type of subcortical dementia?",
      "choices": [
        {
          "id": 1,
          "text": "Pick's disease"
        },
        {
          "id": 2,
          "text": "Parkinson's disease"
        },
        {
          "id": 3,
          "text": "Huntington's disease"
        },
        {
          "id": 4,
          "text": "Wilson's disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Pick's disease </strong>(a type of frontotemporal dementia) is a type of <strong>cortical dementia.</strong></p>\n<div class=\"ng-scope\">\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Cortical dementia</strong></td>\n<td><strong>Subcortical dementia</strong>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Site of lesion </strong><strong>&nbsp;</strong></td>\n<td>Cortex</td>\n<td>Thalamus, basal ganglia, cerebellum, brain stem</td>\n</tr>\n<tr>\n<td><strong>Higher cortical symptoms</strong></td>\n<td>\n<p>Aphasia</p>\n<p>Apraxia</p>\n<p>Agnosia</p>\n<p>Prosopagnosia</p>\n<p>Acalculia</p>\n</td>\n<td>No</td>\n</tr>\n<tr>\n<td><strong>Motor symptoms</strong></td>\n<td>No</td>\n<td>\n<p>Dysarthria</p>\n<p>Tremors</p>\n<p>Ataxia</p>\n<p>Rigidity</p>\n</td>\n</tr>\n<tr>\n<td><strong>Memory</strong></td>\n<td>Recall and recognition are impaired</td>\n<td>Recall is impaired</td>\n</tr>\n<tr>\n<td><strong>Examples</strong></td>\n<td>\n<ul>\n<li>Alzheimer's disease</li>\n<li>Fronto-temporal dementia</li>\n<li>Creutzfeldt Jakob disease</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Parkinson's disease</li>\n<li>Progressive supranuclear palsy</li>\n<li>Huntington's disease</li>\n<li>Wilson's disease</li>\n<li>Idiopathic basal ganglia calcification&nbsp;</li>\n<li>Normal-pressure hydrocephalus</li>\n<li>Vascular dementia</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div><hr><h3>Related Pearl: Differential diagnosis of dementia</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Condition</strong></span></td>\n<td><span><strong>Features</strong></span></td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Alzheimer&rsquo;s disease</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Insidious onset</span></li>\n<li><strong><span>Short-term memory loss</span></strong></li>\n<li><span>Language deficits and spatial disorientation</span></li>\n<li><span>Later, personality changes</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Vascular Dementia</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Stepwise decline</span></li>\n<li><strong><span>Early executive dysfunction</span></strong></li>\n<li><span>Cerebral infarction &amp;/or deep white matter changes on neuroimaging</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Frontotemporal dementia</strong></span></div>\n<div><span><strong>(Pick&rsquo;s disease)</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Early <strong>personality changes</strong></span></li>\n<li><span>Apathy, disinhibition &amp; compulsive behaviors</span></li>\n<li><span>Frontotemporal atrophy on neuroimaging</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Dementia with Lewy bodies</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span><strong>Visual Hallucination</strong></span></li>\n<li><span>Spontaneous parkinsonism</span></li>\n<li><span>Fluctuating cognition</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Normal-pressure hydrocephalus</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Gait abnormalities&nbsp;</span></li>\n<li><span>Urinary Incontinence</span></li>\n<li><span>Dementia</span></li>\n<li><strong><span>Dilated ventricles on neuroimaging</span></strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Creutzfeldt-Jakob disease</strong></span></div>\n<div><span><strong>(Prion disease)</strong></span></div>\n</td>\n<td>\n<ul>\n<li><strong><span>Behavioral changes</span></strong></li>\n<li><span>Rapidly progressive</span></li>\n<li><span>Myoclonus and/or seizures</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6703",
      "difficulty": "medium"
    },
    {
      "text": "A 75-year-old woman has been frequently misplacing her spectacles. Her son criticizes her for not keeping her spectacles in the same place which gets her agitated. She starts shouting and accusing her son and often ends up crying. What is this phenomenon called?",
      "choices": [
        {
          "id": 1,
          "text": "Brief psychotic episode"
        },
        {
          "id": 2,
          "text": "Altruism"
        },
        {
          "id": 3,
          "text": "Catharsis"
        },
        {
          "id": 4,
          "text": "Catastrophic reaction"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical history of old age and the frequent misplacing of spectacles (memory loss) points towards <strong>dementia</strong>. The associated history of over-reaction and agitation is suggestive of <strong>catastrophic reaction.&nbsp;</strong></p>\n<p>In catastrophic reactions, patients&nbsp;<strong>overreact </strong>and <strong>become agitated&nbsp;</strong>when confronted with their cognitive limitations or when facing changes in routine or environment. It is frequently seen in elderly patients with dementia.&nbsp;</p>\n<p>Option A:&nbsp;The given scenario is not a brief psychotic episode because of the absence of psychotic symptoms.</p>\n<p>Option B:&nbsp;Altruism is the selfless behavior of helping another member of the community; putting another person's need before one's own and learning that there is value in giving to others.</p>\n<p>Option C:&nbsp;Catharsis is the expression of ideas, thoughts, and suppressed material that is accompanied by an emotional response that produces a state of relief in the patient.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0313",
      "difficulty": "medium"
    },
    {
      "text": "A 70-year-old woman was evaluated for memory problems. Her husband first noticed the issue about  4 or 5 years back but attributed the symptoms to old age. Gradually her forgetfulness worsened and began to interfere with her daily activities such as housekeeping. A month ago, she got lost while returning from the church which she had been visiting regularly for the past 30 years. No personality changes, rigidity, or gait disturbances were observed. What is the most probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Alzheimer's disease"
        },
        {
          "id": 2,
          "text": "Vascular dementia"
        },
        {
          "id": 3,
          "text": "Dementia with Lewy bodies"
        },
        {
          "id": 4,
          "text": "Pick's disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario of <strong>insidious loss of episodic memory</strong> followed by <strong>slowly progressive dementia</strong> is suggestive of <strong>Alzheimer&rsquo;s disease.</strong>&nbsp;This&nbsp;primarily involves the neurodegeneration of the cholinergic system<strong>.</strong></p>\n<p>Alzheimer's disease is the <strong>most common </strong>cause of dementia, followed by&nbsp;vascular&nbsp;dementia and&nbsp;Lewy body dementia.</p>\n<p>Option B: Absence of prior cerebrovascular accident history or focal neurological deficits rules out vascular dementia. &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>\n<p>Option C: Absence of gait disturbance, rigidity (Parkinsonism) rules out dementia with Lewy bodies.&nbsp;</p>\n<p>Option D: Absence of early personality changes rules out Pick's disease.</p><hr><h3>Related Pearl: Alzheimer’s disease</h3><p><strong>Alzheimer’s disease:</strong></p>\n<ul>\n<li>Age of onset &gt; 60 years</li>\n<li>Mini-mental state examination (MMSE) &lt; 24</li>\n<li>Diagnosis: Clinical\n<ul>\n<li>2 or more areas of cognitive deficits</li>\n<li>Progressive worsening of memory and other cognitive function</li>\n<li>No disturbance in consciousness</li>\n<li>Other systemic causes must be ruled out </li>\n</ul>\n</li>\n</ul>\n<p><strong>Risk Factors:</strong></p>\n<ul>\n<li>Most important risk factor: Old age</li>\n<li>Other risk factors – Family history, presenilin-1, presenilin-2, Apolipoprotein E4 <strong><strong>(ApoE ε4 allele)</strong></strong>, Ubiquitin, Down syndrome and smoking.</li>\n</ul>\n<p><strong>Protective factors:</strong> NSAIDs and Apolipoprotein <strong>E2</strong></p>\n<p><strong>Causes: </strong>Decrease in <strong>acetylcholine</strong> causing depletion of the cholinergic neurons in the <strong>nucleus basalis of Meynert</strong> resulting in short-term memory defects. </p>\n<p><strong>Early findings:</strong></p>\n<ul>\n<li><strong>Anterograde</strong> memory loss (immediate recall affected, distant memories preserved)</li>\n<li><strong>Visuospatial deficits</strong> (lost in own neighborhood)</li>\n<li><strong>Language difficulties</strong> (difficulty finding words)</li>\n<li><strong>Cognitive impairment</strong> with a progressive decline</li>\n<li>Anosognosia </li>\n<li>Visual processing dysfunction (posterior cortical atrophy syndrome)</li>\n<li>Difficulties with naming and repetition (logopenic aphasia)</li>\n</ul>\n<p><strong>Late findings:</strong></p>\n<ul>\n<li>Psychotic symptoms: <strong>delusions</strong></li>\n<li><strong>Apraxia</strong>: Difficulty to perform learned motor tasks</li>\n<li><strong>Lack of insight</strong> regarding deficits</li>\n<li>Non-cognitive neurologic deficits: Pyramidal and extrapyramidal, myoclonus and seizures</li>\n<li>disrupted sleep - wake pattern.</li>\n<li><strong>Urinary incontinence.</strong></li>\n<li>Loss of procedural memory</li>\n</ul>\n<p><strong>Histopathology:</strong></p>\n<ul>\n<li><strong>Senile plaques</strong> (amyloid deposits), <strong>neurofibrillary tangles</strong> (composed of <strong>tau</strong> proteins), neuronal loss, synaptic loss, and granulovacuolar degeneration of neurons.</li>\n</ul>\n<p>The image below shows neurofibrillary tangles in Alzheimer's disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e5db3b220b5c4a6fb0a82d0c724c68c5x640x784.JPEG\" alt=\"Pearl Image\"><p><strong>CT/MRI:</strong></p>\n<ul>\n<li>Later stages: Cortical and subcortical atrophy prominent in parietal and temporal lobes, particularly <strong>hippocampus</strong>. </li>\n</ul>\n<p><strong>Treatment:</strong></p>\n<ul>\n<li>NMDA antagonist: <strong>memantine</strong></li>\n<li>Cholinesterase inhibitors: <strong>donepezil</strong>, <strong>galantamine</strong>, <strong>rivastigmine</strong>.</li>\n<li>Monoclonal antibodies against the N-terminus of the Aβ peptide - <strong>l</strong><strong>ecanemab, donanemab</strong></li>\n</ul><hr><h3>Related Pearl: Differential diagnosis of dementia</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Condition</strong></span></td>\n<td><span><strong>Features</strong></span></td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Alzheimer&rsquo;s disease</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Insidious onset</span></li>\n<li><strong><span>Short-term memory loss</span></strong></li>\n<li><span>Language deficits and spatial disorientation</span></li>\n<li><span>Later, personality changes</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Vascular Dementia</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Stepwise decline</span></li>\n<li><strong><span>Early executive dysfunction</span></strong></li>\n<li><span>Cerebral infarction &amp;/or deep white matter changes on neuroimaging</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Frontotemporal dementia</strong></span></div>\n<div><span><strong>(Pick&rsquo;s disease)</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Early <strong>personality changes</strong></span></li>\n<li><span>Apathy, disinhibition &amp; compulsive behaviors</span></li>\n<li><span>Frontotemporal atrophy on neuroimaging</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Dementia with Lewy bodies</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span><strong>Visual Hallucination</strong></span></li>\n<li><span>Spontaneous parkinsonism</span></li>\n<li><span>Fluctuating cognition</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Normal-pressure hydrocephalus</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Gait abnormalities&nbsp;</span></li>\n<li><span>Urinary Incontinence</span></li>\n<li><span>Dementia</span></li>\n<li><strong><span>Dilated ventricles on neuroimaging</span></strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Creutzfeldt-Jakob disease</strong></span></div>\n<div><span><strong>(Prion disease)</strong></span></div>\n</td>\n<td>\n<ul>\n<li><strong><span>Behavioral changes</span></strong></li>\n<li><span>Rapidly progressive</span></li>\n<li><span>Myoclonus and/or seizures</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0936",
      "difficulty": "easy"
    },
    {
      "text": "A 60-year-old woman who has been having progressive cognitive impairment for the past few years, recently started having hallucinations and strange delusions. Her MRI showed cortical and subcortical atrophy prominent in the parietal and temporal lobes. Which of the following statements are true regarding her condition?<div class='question-desc-html'><ol class=\"ol1\">\n<li class=\"li1\">There is a depletion of cholinergic neurons</li>\n<li class=\"li1\">Visuospatial deficits followed by memory impairment</li>\n<li class=\"li1\">Apolipoprotein E4 is protective&nbsp;</li>\n<li class=\"li1\">Neurofibrillary tangles are present</li>\n<li class=\"li1\">Apolipoprotein E2 is a risk factor</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 and 4"
        },
        {
          "id": 2,
          "text": "1, 3 and 5"
        },
        {
          "id": 3,
          "text": "1, 2 and 4"
        },
        {
          "id": 4,
          "text": "2, 3 and 5"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p class=\"p1\">The given clinical scenario of a patient with&nbsp;progressive cognitive impairment and cortical and subcortical atrophy in the parietal and temporal lobes&nbsp;is suggestive of <strong>Alzheimer's disease</strong> (AD).</p>\n<p class=\"p1\">Statement 2:&nbsp;In Alzheimer's disease, memory impairment is <strong>followed by</strong> visuospatial defects.<br />Statement 3 and 5: Apolipoprotein E4 is a <strong>risk factor</strong> for Alzheimer's disease while apolipoprotein E2 is <strong>protective</strong>.</p><hr><h3>Related Pearl: Alzheimer’s disease</h3><p><strong>Alzheimer’s disease:</strong></p>\n<ul>\n<li>Age of onset &gt; 60 years</li>\n<li>Mini-mental state examination (MMSE) &lt; 24</li>\n<li>Diagnosis: Clinical\n<ul>\n<li>2 or more areas of cognitive deficits</li>\n<li>Progressive worsening of memory and other cognitive function</li>\n<li>No disturbance in consciousness</li>\n<li>Other systemic causes must be ruled out </li>\n</ul>\n</li>\n</ul>\n<p><strong>Risk Factors:</strong></p>\n<ul>\n<li>Most important risk factor: Old age</li>\n<li>Other risk factors – Family history, presenilin-1, presenilin-2, Apolipoprotein E4 <strong><strong>(ApoE ε4 allele)</strong></strong>, Ubiquitin, Down syndrome and smoking.</li>\n</ul>\n<p><strong>Protective factors:</strong> NSAIDs and Apolipoprotein <strong>E2</strong></p>\n<p><strong>Causes: </strong>Decrease in <strong>acetylcholine</strong> causing depletion of the cholinergic neurons in the <strong>nucleus basalis of Meynert</strong> resulting in short-term memory defects. </p>\n<p><strong>Early findings:</strong></p>\n<ul>\n<li><strong>Anterograde</strong> memory loss (immediate recall affected, distant memories preserved)</li>\n<li><strong>Visuospatial deficits</strong> (lost in own neighborhood)</li>\n<li><strong>Language difficulties</strong> (difficulty finding words)</li>\n<li><strong>Cognitive impairment</strong> with a progressive decline</li>\n<li>Anosognosia </li>\n<li>Visual processing dysfunction (posterior cortical atrophy syndrome)</li>\n<li>Difficulties with naming and repetition (logopenic aphasia)</li>\n</ul>\n<p><strong>Late findings:</strong></p>\n<ul>\n<li>Psychotic symptoms: <strong>delusions</strong></li>\n<li><strong>Apraxia</strong>: Difficulty to perform learned motor tasks</li>\n<li><strong>Lack of insight</strong> regarding deficits</li>\n<li>Non-cognitive neurologic deficits: Pyramidal and extrapyramidal, myoclonus and seizures</li>\n<li>disrupted sleep - wake pattern.</li>\n<li><strong>Urinary incontinence.</strong></li>\n<li>Loss of procedural memory</li>\n</ul>\n<p><strong>Histopathology:</strong></p>\n<ul>\n<li><strong>Senile plaques</strong> (amyloid deposits), <strong>neurofibrillary tangles</strong> (composed of <strong>tau</strong> proteins), neuronal loss, synaptic loss, and granulovacuolar degeneration of neurons.</li>\n</ul>\n<p>The image below shows neurofibrillary tangles in Alzheimer's disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e5db3b220b5c4a6fb0a82d0c724c68c5x640x784.JPEG\" alt=\"Pearl Image\"><p><strong>CT/MRI:</strong></p>\n<ul>\n<li>Later stages: Cortical and subcortical atrophy prominent in parietal and temporal lobes, particularly <strong>hippocampus</strong>. </li>\n</ul>\n<p><strong>Treatment:</strong></p>\n<ul>\n<li>NMDA antagonist: <strong>memantine</strong></li>\n<li>Cholinesterase inhibitors: <strong>donepezil</strong>, <strong>galantamine</strong>, <strong>rivastigmine</strong>.</li>\n<li>Monoclonal antibodies against the N-terminus of the Aβ peptide - <strong>l</strong><strong>ecanemab, donanemab</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0314",
      "difficulty": "medium"
    },
    {
      "text": "The memory disorder correctly matched with the pathology is?",
      "choices": [
        {
          "id": 1,
          "text": "Korsakoff syndrome -  hyperactivation of mammillary bodies"
        },
        {
          "id": 2,
          "text": "Alzheimer's disease - loss of synapses"
        },
        {
          "id": 3,
          "text": "Alzheimer's disease - early degeneration of frontal lobe"
        },
        {
          "id": 4,
          "text": "Frontotemporal dementia - mesial temporal lobe atrophy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The cognitive decline in <strong>Alzheimer's disease</strong> is due to the <strong>loss of synapses</strong> and<strong>&nbsp;</strong>neuronal degeneration.</p>\n<p>Microscopically, the following are seen:</p>\n<ul>\n<li>Neuritic plaques&nbsp;- containing amyloid-&beta;</li>\n<li>Neurofibrillary tangles&nbsp;- containing abnormally phosphorylated tau proteins</li>\n<li>Amyloid-&beta; accumulation in the blood vessel walls of the cortex and leptomeninges.</li>\n</ul>\n<p>Option A: In Korsakoff syndrome, there is <strong>inactivation</strong> (not hyperactivation) of <strong>mammillary bodies</strong> due to thiamine deficiency.</p>\n<p>Option C: <strong>Alzheimer's</strong>&nbsp;disease&nbsp;initially affects the parietal and temporal lobe,&nbsp;followed by the <strong>frontal lobe</strong> in the <strong>later</strong> stages. Hence personality changes are a late feature of Alzheimer's.&nbsp;</p>\n<p>Option D: <strong>Mesial temporal lobe atrophy</strong> is very sensitive to <strong>Alzheimer's</strong> disease.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3551",
      "difficulty": "hard"
    },
    {
      "text": "In elderly patients diagnosed with Alzheimer's disease, which of the following mutations is most likely to be seen?",
      "choices": [
        {
          "id": 1,
          "text": "Apolipoprotein E4"
        },
        {
          "id": 2,
          "text": "Presenilin-1"
        },
        {
          "id": 3,
          "text": "Presenilin-2"
        },
        {
          "id": 4,
          "text": "Amyloid Precursor Protein"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Late-onset Alzheimer's disease</strong> is known to be associated with mutations in <strong>a</strong><strong>polipoprotein E4</strong>&nbsp;(<strong>APOE4</strong>) gene.</p>\n<p>Mutations in genetic loci associated with <strong>early-onset</strong> Alzheimer's disease&nbsp;are:</p>\n<ul>\n<li>Amyloid Precursor Protein (<strong>APP</strong>) &ndash; chromosome 21</li>\n<li class=\"page\" title=\"Page 3155\">Presenilin-1 (<strong>PS1</strong>) &ndash; chromosome 14</li>\n<li>Presenilin-2 (<strong>PS2</strong>) &ndash; chromosome 1</li>\n</ul>\n<p>Mutations in genetic loci associated with <strong>late-onset</strong> Alzheimer's disease are:</p>\n<ul>\n<li>Apolipoprotein E4 (<strong>APOE4</strong>) &ndash; chromosome 19</li>\n<li>Triggering Receptor Expressed on Myeloid Cells 2<strong>&nbsp;</strong>(<strong>TREM2</strong>) &ndash; chromosome 6</li>\n</ul>\n<p>Note: Adults with trisomy 21 (Down&rsquo;s syndrome) develop typical neuropathologic hallmarks of AD if they survive beyond age 40.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0318",
      "difficulty": "medium"
    },
    {
      "text": "An elderly man with a long-standing history of memory loss and behavioral changes passed away. On autopsy, atrophy of the brain was noted. A histopathology section of his brain showed the following finding. Which of the following describes the sequence of enzyme action that leads to its development?",
      "choices": [
        {
          "id": 1,
          "text": "α and β secretase"
        },
        {
          "id": 2,
          "text": "α and γ secretase"
        },
        {
          "id": 3,
          "text": "β and γ secretase"
        },
        {
          "id": 4,
          "text": "α, β and γ secretase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of <strong>Alzheimer&rsquo;s disease</strong> and the given image shows&nbsp;abnormal<strong> amyloid plaques&nbsp;</strong>(&beta;-amyloid peptide - A&beta;).&nbsp;<strong>&beta;- and &gamma;-secretase activity</strong> is responsible for its development.</p>\n<p>Excess production of<strong> toxic amyloid</strong>&nbsp;<strong>A&beta; 42</strong> initiates cellular damage in Alzheimer&rsquo;s disease.&nbsp;</p>\n<p>The image below depicts an amyloid plaque seen in Alzheimer's disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cbc7572098d54ef6a4b27cdee4882d86x640x481.JPEG\" alt=\"Explanation Image\"><p>The image below depicts neurofibrillary tangles in&nbsp;Alzheimer's disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7f3bbf1680e54bfd89a71923ad9ddcb4x640x784.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/53f64a6913a744649f1396c739490f7a.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0325",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not true about Alzheimer's disease?",
      "choices": [
        {
          "id": 1,
          "text": "Intracellular neurofibrillary tangles are seen"
        },
        {
          "id": 2,
          "text": "Neuritic plaques made of beta amyloid are found"
        },
        {
          "id": 3,
          "text": "Nucleus of Meynert is not affected"
        },
        {
          "id": 4,
          "text": "Short term memory is affected"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Nucleus of Meynert</strong> is affected in Alzheimer's disease.</p>\n<p>Biochemically, there is a reduction of acetylcholine and <strong>degeneration</strong> of <strong>cholinergic neurons</strong> in the <strong>nucleus basalis of Meynert</strong> that project throughout the cortex. There is also noradrenergic and serotonergic depletion due to degeneration of brain stem nuclei such as the locus ceruleus and the dorsal raphe.&nbsp;</p>\n<p>Microscopically, there are neuritic plaques containing amyloid-&beta;, neurofibrillary tangles, and amyloid-&beta; accumulation in the blood vessel walls of the cortex and leptomeninges.</p><p><span data-preserver-spaces=\"true\">The FDA recently approved<strong> Flortaucipir F18</strong> for <strong>intravenous injection</strong>, the <strong>first radioactive diagnostic agent</strong> for adult patients with cognitive impairment who are being evaluated for Alzheimer&rsquo;s disease. It is indicated for <strong>PET imaging of the brain</strong> to estimate the density and distribution of aggregated <strong>tau</strong> neurofibrillary tangles (NFTs), a primary marker of Alzheimer&rsquo;s disease.</span></p><hr><h3>Related Pearl: Alzheimer’s disease</h3><p><strong>Alzheimer’s disease:</strong></p>\n<ul>\n<li>Age of onset &gt; 60 years</li>\n<li>Mini-mental state examination (MMSE) &lt; 24</li>\n<li>Diagnosis: Clinical\n<ul>\n<li>2 or more areas of cognitive deficits</li>\n<li>Progressive worsening of memory and other cognitive function</li>\n<li>No disturbance in consciousness</li>\n<li>Other systemic causes must be ruled out </li>\n</ul>\n</li>\n</ul>\n<p><strong>Risk Factors:</strong></p>\n<ul>\n<li>Most important risk factor: Old age</li>\n<li>Other risk factors – Family history, presenilin-1, presenilin-2, Apolipoprotein E4 <strong><strong>(ApoE ε4 allele)</strong></strong>, Ubiquitin, Down syndrome and smoking.</li>\n</ul>\n<p><strong>Protective factors:</strong> NSAIDs and Apolipoprotein <strong>E2</strong></p>\n<p><strong>Causes: </strong>Decrease in <strong>acetylcholine</strong> causing depletion of the cholinergic neurons in the <strong>nucleus basalis of Meynert</strong> resulting in short-term memory defects. </p>\n<p><strong>Early findings:</strong></p>\n<ul>\n<li><strong>Anterograde</strong> memory loss (immediate recall affected, distant memories preserved)</li>\n<li><strong>Visuospatial deficits</strong> (lost in own neighborhood)</li>\n<li><strong>Language difficulties</strong> (difficulty finding words)</li>\n<li><strong>Cognitive impairment</strong> with a progressive decline</li>\n<li>Anosognosia </li>\n<li>Visual processing dysfunction (posterior cortical atrophy syndrome)</li>\n<li>Difficulties with naming and repetition (logopenic aphasia)</li>\n</ul>\n<p><strong>Late findings:</strong></p>\n<ul>\n<li>Psychotic symptoms: <strong>delusions</strong></li>\n<li><strong>Apraxia</strong>: Difficulty to perform learned motor tasks</li>\n<li><strong>Lack of insight</strong> regarding deficits</li>\n<li>Non-cognitive neurologic deficits: Pyramidal and extrapyramidal, myoclonus and seizures</li>\n<li>disrupted sleep - wake pattern.</li>\n<li><strong>Urinary incontinence.</strong></li>\n<li>Loss of procedural memory</li>\n</ul>\n<p><strong>Histopathology:</strong></p>\n<ul>\n<li><strong>Senile plaques</strong> (amyloid deposits), <strong>neurofibrillary tangles</strong> (composed of <strong>tau</strong> proteins), neuronal loss, synaptic loss, and granulovacuolar degeneration of neurons.</li>\n</ul>\n<p>The image below shows neurofibrillary tangles in Alzheimer's disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e5db3b220b5c4a6fb0a82d0c724c68c5x640x784.JPEG\" alt=\"Pearl Image\"><p><strong>CT/MRI:</strong></p>\n<ul>\n<li>Later stages: Cortical and subcortical atrophy prominent in parietal and temporal lobes, particularly <strong>hippocampus</strong>. </li>\n</ul>\n<p><strong>Treatment:</strong></p>\n<ul>\n<li>NMDA antagonist: <strong>memantine</strong></li>\n<li>Cholinesterase inhibitors: <strong>donepezil</strong>, <strong>galantamine</strong>, <strong>rivastigmine</strong>.</li>\n<li>Monoclonal antibodies against the N-terminus of the Aβ peptide - <strong>l</strong><strong>ecanemab, donanemab</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7324",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is not true regarding the management of Alzheimer's disease?",
      "choices": [
        {
          "id": 1,
          "text": "Donepezil is the only drug approved for all stages of the disease."
        },
        {
          "id": 2,
          "text": "Monoclonal antibodies can be used in the treatment of Alzheimer's disease."
        },
        {
          "id": 3,
          "text": "Memantine is an NMDA antagonist used in moderate to severe disease."
        },
        {
          "id": 4,
          "text": "Galantamine, Rivastigmine and Benztropine are all used in the treatment of Alzheimer's disease."
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Benztropine</strong> (anticholinergic) is not indicated in Alzheimer's disease.</p>\n<p>The characteristic feature of <strong>Alzheimer's</strong> is the degeneration of cholinergic neurons leading to <strong>decreased </strong>levels of<strong> acetylcholine</strong>. Benztropine, a <strong>muscarinic receptor antagonist,</strong> would block acetylcholine receptors and <strong>worsen symptoms</strong>.</p>\n<p>Donepezil, Galantamine, and Rivastigmine are all acetylcholinesterase inhibitors used in the management of Alzheimer's disease. Donepezil is the only drug approved for all stages of Alzheimer's disease. </p>\n<p>Memantine is an NMDA receptor antagonist used in moderate to severe cases.</p><p>Amyloid beta-directed<strong> monoclonal antibodies</strong> approved for the treatment of Alzheimer's disease are -<strong> lecanemab, </strong><strong>donanemab, </strong>aducanumab </p>\n<p>Note- Aducanumab has been discontinued in the treatment of Alzheimer's</p><hr><h3>Related Pearl: Alzheimer’s disease</h3><p><strong>Alzheimer’s disease:</strong></p>\n<ul>\n<li>Age of onset &gt; 60 years</li>\n<li>Mini-mental state examination (MMSE) &lt; 24</li>\n<li>Diagnosis: Clinical\n<ul>\n<li>2 or more areas of cognitive deficits</li>\n<li>Progressive worsening of memory and other cognitive function</li>\n<li>No disturbance in consciousness</li>\n<li>Other systemic causes must be ruled out </li>\n</ul>\n</li>\n</ul>\n<p><strong>Risk Factors:</strong></p>\n<ul>\n<li>Most important risk factor: Old age</li>\n<li>Other risk factors – Family history, presenilin-1, presenilin-2, Apolipoprotein E4 <strong><strong>(ApoE ε4 allele)</strong></strong>, Ubiquitin, Down syndrome and smoking.</li>\n</ul>\n<p><strong>Protective factors:</strong> NSAIDs and Apolipoprotein <strong>E2</strong></p>\n<p><strong>Causes: </strong>Decrease in <strong>acetylcholine</strong> causing depletion of the cholinergic neurons in the <strong>nucleus basalis of Meynert</strong> resulting in short-term memory defects. </p>\n<p><strong>Early findings:</strong></p>\n<ul>\n<li><strong>Anterograde</strong> memory loss (immediate recall affected, distant memories preserved)</li>\n<li><strong>Visuospatial deficits</strong> (lost in own neighborhood)</li>\n<li><strong>Language difficulties</strong> (difficulty finding words)</li>\n<li><strong>Cognitive impairment</strong> with a progressive decline</li>\n<li>Anosognosia </li>\n<li>Visual processing dysfunction (posterior cortical atrophy syndrome)</li>\n<li>Difficulties with naming and repetition (logopenic aphasia)</li>\n</ul>\n<p><strong>Late findings:</strong></p>\n<ul>\n<li>Psychotic symptoms: <strong>delusions</strong></li>\n<li><strong>Apraxia</strong>: Difficulty to perform learned motor tasks</li>\n<li><strong>Lack of insight</strong> regarding deficits</li>\n<li>Non-cognitive neurologic deficits: Pyramidal and extrapyramidal, myoclonus and seizures</li>\n<li>disrupted sleep - wake pattern.</li>\n<li><strong>Urinary incontinence.</strong></li>\n<li>Loss of procedural memory</li>\n</ul>\n<p><strong>Histopathology:</strong></p>\n<ul>\n<li><strong>Senile plaques</strong> (amyloid deposits), <strong>neurofibrillary tangles</strong> (composed of <strong>tau</strong> proteins), neuronal loss, synaptic loss, and granulovacuolar degeneration of neurons.</li>\n</ul>\n<p>The image below shows neurofibrillary tangles in Alzheimer's disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e5db3b220b5c4a6fb0a82d0c724c68c5x640x784.JPEG\" alt=\"Pearl Image\"><p><strong>CT/MRI:</strong></p>\n<ul>\n<li>Later stages: Cortical and subcortical atrophy prominent in parietal and temporal lobes, particularly <strong>hippocampus</strong>. </li>\n</ul>\n<p><strong>Treatment:</strong></p>\n<ul>\n<li>NMDA antagonist: <strong>memantine</strong></li>\n<li>Cholinesterase inhibitors: <strong>donepezil</strong>, <strong>galantamine</strong>, <strong>rivastigmine</strong>.</li>\n<li>Monoclonal antibodies against the N-terminus of the Aβ peptide - <strong>l</strong><strong>ecanemab, donanemab</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0321",
      "difficulty": "medium"
    },
    {
      "text": "An elderly patient was referred from the medicine OPD with paranoid ideation and suspiciousness. He has also been having inappropriate outbursts of rage for the past 1 year and memory issues for the past 3 months. He is unable to dress by himself or manage his daily activities, such as cooking or cleaning. Imaging was done and the following findings were seen. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Alzheimer’s disease"
        },
        {
          "id": 2,
          "text": "Pick’s disease"
        },
        {
          "id": 3,
          "text": "Vascular dementia"
        },
        {
          "id": 4,
          "text": "Lewy-body dementia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p class=\"p1\">The given clinical scenario and the scan indicating atrophy of frontal and parietal lobes are suggestive of <strong>frontotemporal dementia (FTD),</strong> one of which is <strong>Pick's disease. </strong></p>\n<p>Pick's disease presents with <strong>early&nbsp;personality changes&nbsp;</strong>(frontal lobe involvement)<strong>&nbsp;</strong>and loss of social restraints initially,&nbsp;<strong>followed by memory loss</strong>.&nbsp;By contrast, Alzheimer's patients present with memory loss first and then develop personality changes.&nbsp;</p>\n<p>Other features include loss of insight, easy distractibility, reduced concern or empathy for others, emotional lability or withdrawal, impulsiveness, poor self-care, and perseveration.</p>\n<p class=\"p1\">There is a second type of presentation of FTD, which is characterized by an&nbsp;<strong>early and progressive change in language</strong>, with problems of expression of language or severe naming difficulty, and problems with word meaning.</p>\n<p>The classic imaging findings&nbsp;seen in FTD are&nbsp;preferential<strong> atrophy </strong>of the <strong>frontal and temporal lobes</strong> with <strong>occipitoparietal sparing</strong>.</p>\n<p>A sagittal section brain MRI is given below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2542e7b481504d71b87282ba57aa7038x630x630.JPEG\" alt=\"Explanation Image\"><p><strong>Histopathology:</strong></p>\n<ul>\n<li><strong>Pick cells</strong> (swollen neurons) in affected areas of the brain</li>\n<li><strong>Pick bodies</strong> (intraneuronal argentophilic inclusions)</li>\n</ul>\n<p>In the image below, the arrows point to the pick bodies in the frontal cortex.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/aa5f472a3854450bbf708052c7566857x718x1062.PNG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b026ae725d84401fafd5b8dab2ab0a9a.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0324",
      "difficulty": "medium"
    },
    {
      "text": "A 62-year-old man was taken to a psychiatrist by his family with complaints of strange behavior. He has been inappropriately making sexual remarks and was caught urinating in public. Recently, he created a ruckus by cracking jokes and laughing out loud at a funeral. On evaluation, there was a deficit in executive functioning and working memory. What is the most common genetic change associated with the given clinical condition?",
      "choices": [
        {
          "id": 1,
          "text": "Hexanucleotide repeat expansion"
        },
        {
          "id": 2,
          "text": "Trinucleotide repeat expansion"
        },
        {
          "id": 3,
          "text": "Deletion"
        },
        {
          "id": 4,
          "text": "Point mutation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of <strong>frontotemporal dementia</strong>&nbsp;(FTD).<strong>&nbsp;</strong>The <strong>most common</strong>&nbsp;genetic abnormality associated with&nbsp;FTD is a <strong>hexanucleotide expansion</strong> of the gene <strong>C9orf72</strong>.&nbsp;</p>\n<p>Other mutations causing frontotemporal dementia:</p>\n<ul>\n<li><strong>Progranulin</strong> (<strong>GRN</strong>) mutation on chromosome 17</li>\n<li><strong>Microtubule-associated protein tau</strong> (<strong>MAPT</strong>) mutation on&nbsp;chromosome 17.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0323",
      "difficulty": "hard"
    },
    {
      "text": "A 70-year-old veteran army officer presents with difficulty in concentrating,  increased forgetfulness, repeated falls due to sluggish movement and also complains of seeing recurrent red animal figures for a few weeks. Which of the following is most likely?",
      "choices": [
        {
          "id": 1,
          "text": "Frontotemporal dementia"
        },
        {
          "id": 2,
          "text": "Dementia with lewy bodies"
        },
        {
          "id": 3,
          "text": "Alzheimer’s disease"
        },
        {
          "id": 4,
          "text": "Post Traumatic Stress Disorder"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario of dementia associated with <strong>hallucinations</strong> is suggestive of <strong>d</strong><strong>ementia with Lewy bodies.</strong></p>\n<p>Core clinical features&nbsp;(the first three typically occur early and may persist throughout the course):</p>\n<ul>\n<li><strong>Fluctuating cognition</strong> with pronounced variations in attention and alertness.</li>\n<li>Recurrent <strong>visual hallucinations</strong>&nbsp;that are typically well-formed and detailed.</li>\n<li><strong>REM sleep behavior disorder </strong>which&nbsp;may precede cognitive decline.</li>\n<li>One or more spontaneous cardinal features of<strong>&nbsp;Parkinsonism</strong> (bradykinesia, rest tremor, rigidity).</li>\n</ul>\n<p>Note:&nbsp;A new study found that older adults who frequently used sleep medications were 40% more likely to develop dementia over 15 years.</p><hr><h3>Related Pearl: Differential diagnosis of dementia</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Condition</strong></span></td>\n<td><span><strong>Features</strong></span></td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Alzheimer&rsquo;s disease</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Insidious onset</span></li>\n<li><strong><span>Short-term memory loss</span></strong></li>\n<li><span>Language deficits and spatial disorientation</span></li>\n<li><span>Later, personality changes</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Vascular Dementia</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Stepwise decline</span></li>\n<li><strong><span>Early executive dysfunction</span></strong></li>\n<li><span>Cerebral infarction &amp;/or deep white matter changes on neuroimaging</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Frontotemporal dementia</strong></span></div>\n<div><span><strong>(Pick&rsquo;s disease)</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Early <strong>personality changes</strong></span></li>\n<li><span>Apathy, disinhibition &amp; compulsive behaviors</span></li>\n<li><span>Frontotemporal atrophy on neuroimaging</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Dementia with Lewy bodies</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span><strong>Visual Hallucination</strong></span></li>\n<li><span>Spontaneous parkinsonism</span></li>\n<li><span>Fluctuating cognition</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Normal-pressure hydrocephalus</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Gait abnormalities&nbsp;</span></li>\n<li><span>Urinary Incontinence</span></li>\n<li><span>Dementia</span></li>\n<li><strong><span>Dilated ventricles on neuroimaging</span></strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Creutzfeldt-Jakob disease</strong></span></div>\n<div><span><strong>(Prion disease)</strong></span></div>\n</td>\n<td>\n<ul>\n<li><strong><span>Behavioral changes</span></strong></li>\n<li><span>Rapidly progressive</span></li>\n<li><span>Myoclonus and/or seizures</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0319",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old woman, with a history of hypertension and hyperlipidemia, was referred to the psychiatry OPD for evaluation of memory loss and depression. Which of the following features is least suggestive of vascular dementia in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Focal neurological deficits"
        },
        {
          "id": 2,
          "text": "Stepladder deterioration"
        },
        {
          "id": 3,
          "text": "White matter lesions on MRI"
        },
        {
          "id": 4,
          "text": "Chronic, gradual course"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In classic vascular dementia, since infarcts are accumulated in a stepwise fashion, deterioration is similarly <strong>abrupt and stepwise</strong> rather than smoothly gradual.&nbsp;</p>\n<p>The criteria for the clinical diagnosis of vascular dementia include:</p>\n<ul>\n<li><strong>Cognitive decline</strong> from a previously higher level of functioning</li>\n<li>Presence of <strong>focal signs</strong> on neurological examination, consistent with stroke</li>\n<li>A relationship between the above two, based on the presence of one or more of the following:\n<ul>\n<li>Onset of dementia within 3 months following a recognized stroke</li>\n<li>Abrupt deterioration in cognitive functions, or fluctuating, stepwise progression of cognitive deficits.</li>\n</ul>\n</li>\n</ul>\n<p>Imaging findings in vascular dementia include extensive leukoencephalopathy (<strong>white matter lesions</strong>), resulting from&nbsp;cerebral small-vessel disease or a variable number of infarcts in large-vessel territories.&nbsp;</p>\n<p>Note: Subcortical or small vessel dementia, can sometimes have an insidious onset.&nbsp;</p><p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Population data suggest that the risk of developing dementia, both vascular and neurodegenerative, among people with diabetes followed for 20 years is roughly double that of those without diabetes. &quot;}\" data-sheets-userformat=\"{&quot;2&quot;:33555261,&quot;3&quot;:{&quot;1&quot;:0},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0,&quot;28&quot;:1}\">Population data suggest that the risk of developing dementia, both vascular and neurodegenerative, among people with diabetes followed for 20 years is roughly double that of those without diabetes. </span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0338",
      "difficulty": "medium"
    }
  ]
}